161 related articles for article (PubMed ID: 37704550)
61. Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
Takahashi Y; Biller BMK; Fukuoka H; Ho KKY; Rasmussen MH; Nedjatian N; Sværke C; Yuen KCJ; Johannsson G
Pituitary; 2023 Feb; 26(1):57-72. PubMed ID: 36380045
[TBL] [Abstract][Full Text] [Related]
62. Acromegaly resolution after traumatic brain injury: a case report.
Cob A
J Med Case Rep; 2014 Sep; 8():290. PubMed ID: 25182385
[TBL] [Abstract][Full Text] [Related]
63. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
64. Pituitary disease and pregnancy.
Valassi E
Endocrinol Diabetes Nutr (Engl Ed); 2021 Mar; 68(3):184-195. PubMed ID: 34167698
[TBL] [Abstract][Full Text] [Related]
65. Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.
Ahmad AM; Hopkins MT; Thomas J; Ibrahim H; Fraser WD; Vora JP
Clin Endocrinol (Oxf); 2001 Jun; 54(6):709-17. PubMed ID: 11422104
[TBL] [Abstract][Full Text] [Related]
66. Pituitary tumours: inflammatory and granulomatous expansive lesions of the pituitary.
Carpinteri R; Patelli I; Casanueva FF; Giustina A
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):639-50. PubMed ID: 19945028
[TBL] [Abstract][Full Text] [Related]
67. Anti-pituitary antibodies in patients with hypopituitarism and their families: longitudinal observation.
Kajita K; Yasuda K; Yamakita N; Murai T; Matsuda M; Morita H; Mori A; Murayama M; Tanahashi S; Sugiura M
Endocrinol Jpn; 1991 Apr; 38(2):121-9. PubMed ID: 1661231
[TBL] [Abstract][Full Text] [Related]
68. Development of growth hormone and adrenocorticotropic hormone deficiencies in patients with prenatal or perinatal-onset hypothalamic hypopituitarism having invisible or thin pituitary stalk on magnetic resonance imaging.
Miyamoto J; Hasegawa Y; Ohnami N; Onigata K; Kinoshita E; Nishi Y; Tachibana K; Hasegawa T
Endocr J; 2001 Jun; 48(3):355-62. PubMed ID: 11523907
[TBL] [Abstract][Full Text] [Related]
69. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
[TBL] [Abstract][Full Text] [Related]
70. Traumatic brain injury-induced hypopituitarism in adolescence.
Baldelli R; Bellone S; Corneli G; Savastio S; Petri A; Bona G
Pituitary; 2005; 8(3-4):255-7. PubMed ID: 16508709
[TBL] [Abstract][Full Text] [Related]
71. Diagnosis of GH Deficiency Without GH Stimulation Tests.
Ibba A; Loche S
Front Endocrinol (Lausanne); 2022; 13():853290. PubMed ID: 35250894
[TBL] [Abstract][Full Text] [Related]
72. [Genetic aspects of growth hormone deficiency].
Reynaud R; Castinetti F; Galon-Faure N; Albarel-Loy F; Saveanu A; Quentien MH; Jullien N; Khammar A; Enjalbert A; Barlier A; Brue T
Arch Pediatr; 2011 Jun; 18(6):696-706. PubMed ID: 21497494
[TBL] [Abstract][Full Text] [Related]
73. [Metabolic effects of human growth hormone in adults and children].
ABRAMOW M; CORVILAIN J
Ann Endocrinol (Paris); 1963; 24():145-56. PubMed ID: 14010762
[No Abstract] [Full Text] [Related]
74. Somapacitan: a long-acting growth hormone derivative for treatment of growth hormone deficiency.
Paton DM
Drugs Today (Barc); 2022 Oct; 58(10):509-517. PubMed ID: 36305544
[TBL] [Abstract][Full Text] [Related]
75. Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency.
Losa M; Scavini M; Gatti E; Rossini A; Madaschi S; Formenti I; Caumo A; Stidley CA; Lanzi R
Thyroid; 2008 Dec; 18(12):1249-54. PubMed ID: 19012473
[TBL] [Abstract][Full Text] [Related]
76. [Panhypopituitarism and dwarfism in a man with a primary empty sella turcica (author's transl)].
Turpin G; Jambart S; de Gennes JL
Nouv Presse Med; 1979 Mar; 8(11):847-8, 850. PubMed ID: 450657
[TBL] [Abstract][Full Text] [Related]
77. Growth Hormone Deficiency Following Traumatic Brain Injury in Pediatric and Adolescent Patients: Presentation, Treatment, and Challenges of Transitioning from Pediatric to Adult Services.
Wexler TL; Reifschneider K; Backeljauw P; Cárdenas JF; Hoffman AR; Miller BS; Yuen KCJ
J Neurotrauma; 2023 Jul; 40(13-14):1274-1285. PubMed ID: 36825511
[No Abstract] [Full Text] [Related]
78. Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI).
Aimaretti G; Ambrosio MR; Benvenga S; Borretta G; De Marinis L; De Menis E; Di Somma C; Faustini-Fustini M; Grottoli S; Gasco V; Gasperi M; Logoluso F; Scaroni C; Giordano G; Ghigo E;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S114-7. PubMed ID: 15135791
[TBL] [Abstract][Full Text] [Related]
79. Sheehan's syndrome: clinical profile, pituitary hormone responses and computed sellar tomography.
Dash RJ; Gupta V; Suri S
Aust N Z J Med; 1993 Feb; 23(1):26-31. PubMed ID: 8460969
[TBL] [Abstract][Full Text] [Related]
80. Hypopituitarism following external radiotherapy for pituitary tumours in adults.
Littley MD; Shalet SM; Beardwell CG; Ahmed SR; Applegate G; Sutton ML
Q J Med; 1989 Feb; 70(262):145-60. PubMed ID: 2594955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
